Mice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally

Cited by (495)

Items 301–400 of 495

1. Histone Deacetylases and Cardiometabolic Diseases
   Kan Hui Yiew, Tapan K. Chatterjee, David Y. Hui, Neal L. Weintraub · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
2. Class I Lysine Deacetylases Facilitate Glucocorticoid-induced Transcription*
   V. Kadiyala, Nina M. Patrick, Wana Mathieu, Rosa Jaime-Frias, Naruekamol Pookhao, Ling-Ling An, Catharine L. Smith · 2013 · Journal of Biological Chemistry
3. Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance
   Hyein Jo, Kyeonghee Shim, Dooil Jeoung · 2022 · International Journal of Molecular Sciences
4. Requirement of Histone Deacetylase 6 for Interleukin-6 Induced Epithelial-Mesenchymal Transition, Proliferation, and Migration of Peritoneal Mesothelial Cells
   Ying-Feng Shi, Min Tao, Jun Ni, Lun-Xian Tang, Feng Liu, Hui Chen, Xiao-Yan Ma, Yan Hu, Xun Zhou, An-Dong Qiu et al. · 2021 · Frontiers in Pharmacology
5. Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype
   Olasunkanmi O. Olaoye, Paris R. Watson, Nabanita Nawar, Mulu Geletu, Abootaleb Sedighi, Shazreh Bukhari, Yasir S. Raouf, Pimyupa Manaswiyoungkul, Fettah Erdogan, Ayah Abdeldayem et al. · 2021 · Journal of Medicinal Chemistry
6. Discovery of a fluorescent probe with HDAC6 selective inhibition
   Yingjie Zhang, Yan Jin, Tso‐Pang Yao · 2017 · European Journal of Medicinal Chemistry
7. Synergistic antitumor effects of the combined treatment with an HDAC6 inhibitor and a COX-2 inhibitor through activation of PTEN
   Guanhua Zhang, Yehua Gan · 2017 · Oncology Reports
8. Acetylation in Mitochondria Dynamics and Neurodegeneration
   Jaylyn Waddell, Aditi Banerjee, Tibor Kristián · 2021 · Cells
9. CKD-506: A novel HDAC6-selective inhibitor that exerts therapeutic effects in a rodent model of multiple sclerosis
   Daekwon Bae, Ji‐Young Lee, Nina Ha, Jinsol Park, Jiyeon Baek, Dong‐Hyeon Suh, Hee Seon Lim, Soo Min Ko, TaeHee Kim, Da Som Jeong et al. · 2021 · Scientific Reports
10. The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells
    Huang‐Ju Tu, Yi-Jyun Lin, Min‐Wu Chao, Ting-Yi Sung, Yi-Wen Wu, Yiying Chen, Mei-Hsiang Lin, Jing‐Ping Liou, Shiow‐Lin Pan, Chia‐Ron Yang · 2018 · Clinical Epigenetics
11. Histone Deacetylase 6–Controlled Hsp90 Acetylation Significantly Alters Mineralocorticoid Receptor Subcellular Dynamics But Not its Transcriptional Activity
    Rubén Jiménez-Canino, Fabián Lorenzo-Díaz, Frédéric Jaisser, Nicolette Farman, Teresa Giráldez, Diego Álvarez de la Rosa · 2016 · Endocrinology
12. Technologies of targeting histone deacetylase in drug discovery: Current progress and emerging prospects
    Jinxiao Ru, Yuxi Wang, Zijia Li, Jiaxing Wang, Changyu Ren, Jifa Zhang · 2023 · European Journal of Medicinal Chemistry
13. Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition
    Dahea You, Jason R. Richardson, Lauren M. Aleksunes · 2020 · Drug Metabolism and Disposition
14. Afadin is a scaffold protein repressing insulin action via HDAC6 in adipose tissue
    Morten Lundh, Patricia S. S. Petersen, Marie Sophie Isidor, Dolly NM Kazoka‐Sørensen, Kaja Plucińska, Farnaz Shamsi, Cathrine Ørskov, Marco Tozzi, Erin Louise Brown, Emil Andersen et al. · 2019 · EMBO Reports
15. Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia
    Kamira Karen Maharaj, John Joseph Powers, Alex N. Achille, Susan Deng, Renée Fonseca, Mibel Pabón-Saldaña, Steven N. Quayle, Simon S. Jones, Alejandro Villagra, Eduardo M. Sotomayor et al. · 2018 · Blood Advances
16. Histone deacetylases in kidney development: implications for disease and therapy
    Shaowei Chen, Samir Sayem El-Dahr · 2012 · Pediatric Nephrology
17. HDAC6 Inhibition Reverses Cisplatin-Induced Mechanical Hypersensitivity via Tonic Delta Opioid Receptor Signaling
    Jixiang Zhang, Jazzmine M. Junigan, Ronnie The Phong Trinh, Annemieke Kavelaars, Cobi J. Heijnen, Peter M. Grace · 2022 · Journal of Neuroscience
18. HDAC6 Is Involved in the Histone Deacetylation of In Vitro Maturation Oocytes and the Reprogramming of Nuclear Transplantation in Pig
    Junming Sun, QingYou Liu, Lingyan Lv, Sun RuYu, Zhi Peng Li, Ben Huang, Kuiqing Cui, Deshun Shi · 2021 · Reproductive Sciences
19. Multitarget Inhibition of Histone Deacetylase (HDAC) and Phosphatidylinositol‐3‐kinase (PI3K): Current and Future Prospects
    Daniel Alencar Rodrigues, Pedro de Sena Murteira Pinheiro, Carlos Alberto Manssour Fraga · 2020 · ChemMedChem
20. Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitors
    Ahmed K. ElHady, Shou‐Ping Shih, Yu-Cheng Chen, Yi‐Chang Liu, Nermin S. Ahmed, Adam B. Keeton, Gary Anthony Piazza, Matthias Engel, Alireza Abadi, Mohammad Abdel‐Halim · 2020 · Bioorganic Chemistry
21. Insights of the tubulin code in gametes and embryos: from basic research to potential clinical applications in humans†
    Farners Amargant, Montserrat Barragán, Rita Vassena, Isabelle Vernos · 2018 · Biology of Reproduction
22. A Highly Potent and Selective Histone Deacetylase 6 Inhibitor Prevents DSS-Induced Colitis in Mice
    Ting Liu, Renping Wang, Haojie Xu, Yunlong Song, Yunpeng Qi · 2017 · Biological and Pharmaceutical Bulletin
23. Treatment with a selective histone deacetylase 6 inhibitor decreases lupus nephritis in NZB/W mice.
    Miranda D. Vieson, Alexander M Gojmerac, D. Khan, R. Dai, J. V. van Duzer, Ralph Mazitschek, D. Caudell, Xiao-Feng Liao, Xin M. Luo, C. Reilly · 2017 · Histology and Histopathology
24. A STRIPAK component Strip regulates neuronal morphogenesis by affecting microtubule stability
    Chisako Sakuma, Misako Okumura, Tomoki Umehara, Masayuki Miura, Takahiro Chihara · 2015 · Scientific Reports
25. Epigenetics of the failing heart
    José Marín-García, Alexander T. Akhmedov · 2015 · Heart Failure Reviews
26. Unanchored ubiquitin in virus uncoating
    Ricardo Rajsbaum, Adolfo García‐Sastre · 2014 · Science
27. Effects of 10-Hydroxy-2-decenoic acid on the development of honey bee (Apis mellifera) larvae
    Wen Xiang Wang, Liu Qing Tian, Qiang Huang, Xiao Bo Wu, Zhi Jiang Zeng · 2014 · Journal of Apicultural Research
28. Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer
    Ana M. Vuletić, Katarina Mirjačić Martinović, Jelena Spasić · 2023 · Pharmaceutics
29. HDAC6 inhibitor ACY-1083 shows lung epithelial protective features in COPD
    J. Horndahl, Rebecka Svärd, P. Berntsson, Cecilia Wingren, Jingjing Li, Suado M. Abdillahi, B. Ghosh, Erin Capodanno, Justin H Chan, L. Ripa et al. · 2022 · bioRxiv
30. ATAT1 regulates forebrain development and stress-induced tubulin hyperacetylation
    Lin Li, Sriram Jayabal, Mohammad Ghorbani, Lisa‐Marie Legault, Serge McGraw, Alanna Jean Watt, Xiang‐Jiao Yang · 2019 · Cellular and Molecular Life Sciences
31. A potent hydroxamic acid-based, small-molecule inhibitor A452 preferentially inhibits HDAC6 activity and induces cytotoxicity toward cancer cells irrespective of p53 status
    Hyun-Wook Ryu, Dong-Hee Shin, Dong Hoon Lee, Hye-Rim Won, So Hee Kwon · 2017 · Carcinogenesis
32. The universe of Hsp90
    Marta Stankiewicz, Matthias P. Mayer · 2011 · BioMolecular Concepts
33. Effect of EGF-Induced HDAC6 Activation on Corneal Epithelial Wound Healing
    Jie Wang, Andrew Lin, Luo Lu · 2010 · Investigative Ophthalmology & Visual Science
34. A novel HDAC6 inhibitor, CKD-504, is effective in treating preclinical models of huntington’s disease
    Endan Li, Jiwoo Choi, Hye‐ri Sim, J.-H. Kim, Jae Hyun Jun, Jangbeen Kyung, Nina Ha, Semi Kim, Keun Ho Ryu, Seungsoo Chung et al. · 2023 · BMB Reports
35. Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma
    Daniel J. García-Domínguez, Nabil Hajji, Sara Sánchez-Molina, Elisabet Figuerola-Bou, Rocío M. de Pablos, Ana M. Espinosa‐Oliva, Eduardo Andrés‐León, Laura Carmen Terron-Camero, Rocío Flores-Campos, Guillem Pascual‐Pasto et al. · 2021 · Oncogene
36. A452, an HDAC6‐selective inhibitor, synergistically enhances the anticancer activity of chemotherapeutic agents in colorectal cancer cells
    Hye-Rim Won, Hyun-Wook Ryu, Dong-Hee Shin, Soo-Keun Yeon, Dong-Hoon Lee, S. Kwon · 2018 · Molecular Carcinogenesis
37. α-Tubulin Acetyltransferase Is a Novel Target Mediating Neurite Growth Inhibitory Effects of Chondroitin Sulfate Proteoglycans and Myelin-Associated Glycoprotein
    Victor S. C. Wong, Cristina Picci, Michelle L. Swift, Max Levinson, Dianna E. Willis, Brett C. Langley · 2018 · eNeuro
38. STAT5 acetylation
    Christian Kosan, Torsten Ginter, Thorsten Heinzel, Oliver Holger Krämer · 2013 · JAK-STAT
39. Expression pattern of acetylated α‐tubulin in porcine spermatogonia
    Jinping Luo, Jose Rafael Rodriguez‐Sosa, Lin Tang, Alla A. Bondareva, Susan O. Megee, Ina Dobrinski · 2009 · Molecular Reproduction and Development
40. Recent Advances in the Molecular and Cellular Mechanisms of gp120-Mediated Neurotoxicity
    Valeria Avdoshina, Italo Mocchetti · 2022 · Cells
41. Loss of Deacetylation Enzymes Hdac6 and Sirt2 Promotes Acetylation of Cytoplasmic Tubulin, but Suppresses Axonemal Acetylation in Zebrafish Cilia
    Pawel K Lysyganicz, Niedharsan Pooranachandran, Xinming Liu, Kathryn Isabel Adamson, Katarzyna Zielonka, Stone Elworthy, Fredericus J. van Eeden, Andrew J. Grierson, Jarema J. Malicki · 2021 · Frontiers in Cell and Developmental Biology
42. The epigenetic landscape of rheumatoid arthritis: Pathogenesis and drug therapeutic potentials
    Chengcheng Huang, Yuxiang Liang, Yang Li, Wei Quan, Liang Ouyang, Jifa Zhang · 2025 · Acta Pharmaceutica Sinica B
43. Histone Deacetylases Function in the Control of Early Hematopoiesis and Erythropoiesis
    Pascal Vong, Hakim Ouled‐Haddou, Loïc Garçon · 2022 · International Journal of Molecular Sciences
44. Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder
    Manuela Loi, Laura Gennaccaro, Claudia Fuchs, Stefania Trazzi, Giorgio Medici, Giuseppe Galvani, Nicola Mottolese, Marianna Tassinari, Roberto Rimondini, Andrea Milelli et al. · 2021 · International Journal of Molecular Sciences
45. Chromatin-Modifying Enzymes in T Cell Development
    Michael J. Shapiro, Virginia Smith Shapiro · 2020 · Annual Review of Immunology
46. Restoration of mutant hERG stability by inhibition of HDAC6
    Peili Li, Yasutaka Kurata, Endang Mahati, Haruaki Ninomiya, Katsumi Higaki, Fikri Taufiq, Kumi Morikawa, Yasuaki Shirayoshi, Minoru Horie, Ichiro Hisatome · 2018 · Journal of Molecular and Cellular Cardiology
47. The primary cilium is a self-adaptable, integrating nexus for mechanical stimuli and cellular signaling
    An M. Nguyen, Yuan‐Nan Young, Christopher Rae Jacobs · 2015 · Biology Open
48. CD133-targeted niche-dependent therapy in cancer: a multipronged approach.
    Anthony B. Mak, Caroline I. Schnegg, Chiou-Yan Lai, S. Ghosh, Moon-Hee Yang, J. Moffat, Mei-Yu Hsu · 2014 · American Journal of Pathology
49. Mechanical forces and metabolic changes cooperate to drive cellular memory and endothelial phenotypes
    Jin Li, Yun Hua Fang, David Wu · 2021 · Current topics in membranes
50. HDAC6 inhibitor WT161 induces apoptosis in retinoblastoma cells and synergistically interacts with cisplatin
    Jun Sun, Xia Qian, Feifei Zhang, Xiaofeng Tang, Cheng Ju, Renfeng Liu, Ruihao Zhou, Zhiping Zhang, Xiaobin Lv, Changhua Zhang et al. · 2019 · Translational Cancer Research
51. Structure-based design generated novel hydroxamic acid based preferential HDAC6 lead inhibitor with on-target cytotoxic activity against primary choroid plexus carcinoma
    Shaymaa Emam Kassab, Samar Mowafy, Aya M. Alserw, Joustin A. Seliem, Shahenda El‐Naggar, Nesreen Nabil Omar, Mohamed Medhat Awad · 2019 · Journal of Enzyme Inhibition and Medicinal Chemistry
52. Ripor2 is involved in auditory hair cell stereociliary bundle structure and orientation
    Oscar Diaz‐Horta, Clemer Abad, Filiz Başak Cengiz, Güney Bademci, Patricia Lurie Blackwelder, Katherina Walz, Mustafa Tekin · 2018 · Journal of Molecular Medicine
53. New Insights into the Connection Between Histone Deacetylases, Cell Metabolism, and Cancer
    Ferdinando Chiaradonna, Claudia Cirulli, Roberta Palorini, Giuseppina Votta, Lilia Alberghina · 2014 · Antioxidants and Redox Signaling
54. Aberrant levels of histone H3 acetylation induce spermatid anomaly in mouse testis
    Lei Dai, Daisuke Endo, Naotaro Akiyama, Tomomi Yamamoto‐Fukuda, Takehiko Koji · 2014 · Histochemistry and Cell Biology
55. Chromatin modification and epigenetic control in functional nerve regeneration
    Kalen Berry, Qing Richard Lu · 2019 · Seminars in Cell and Developmental Biology
56. Advances in the Mechanistic Study of the Control of Oxidative Stress Injury by Modulating HDAC6 Activity
    Yuanye Xue, Bing Gan, Yanxing Zhou, Tingyu Wang, Tong Zhu, Xinsheng Peng, Xiangning Zhang, Yanfang Zhou · 2023 · Cell Biochemistry and Biophysics
57. Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344
    Mona Dawood, Edmond Fleischer, Anette Klinger, Gerhard Bringmann, Letian Shan, Thomas Efferth · 2020 · Pharmacological Research
58. Quantitative proteomics analysis reveals alterations of lysine acetylation in mouse testis in response to heat shock and X-ray exposure
    Chengmei Xie, Hongyan Shen, Hui Zhang, Jinting Yan, Yang Liu, Fuwen Yao, Xi Wang, Zhongyi Cheng, Tie-Shan Tang, Caixia Guo · 2017 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
59. Exploration of thiaheterocyclic hHDAC6 inhibitors as potential antiplasmodial agents
    Rob De Vreese, C. de Kock, P. Smith, K. Chibale, M. D'Hooghe · 2017 · Future Medicinal Chemistry
60. Overexpression of Hdac6 extends reproductive lifespan in mice
    Xiaoxi Zhang, Jiao Yang, Haiying Wang, Renpeng Guo, Yu Yin, Dongdong Zhang, Qian Zhang, Hua Wang, Zhongcheng Zhou, Lingyi Chen et al. · 2017 · Protein & Cell
61. HDAC6 deficiency or inhibition blocks FGFR3 accumulation and improves bone growth in a model of achondroplasia
    Sara Ota, Zi-Qiang Zhou, Megan P. Romero, Guang Yang, Peter J. Hurlin · 2016 · Human Molecular Genetics
62. Involvement of transcription factor XBP1s in the resistance of HDAC6 inhibitor Tubastatin A to superoxidation via acetylation-mediated proteasomal degradation
    Yue Zhang, Chang‐Mei Liu, Xian-cao Cao, Yi Zang, Yubo Zhou, Jia Xuan Li · 2014 · Biochemical and Biophysical Research Communications
63. Class II HDACs and Neuronal Regeneration
    Bor Luen Tang · 2014 · Journal of Cellular Biochemistry
64. Primary and Motile Cilia: Their Ultrastructure and Ciliogenesis
    Sigrid Hoyer‐Fender · 2012 · Springer eBooks
65. Rationale for HDAC Inhibitor Therapy in Autoimmunity and Transplantation
    Wayne W. Hancock · 2011 · Handbook of experimental pharmacology
66. Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory properties
    Fabian B. Kraft, Jana Enns, Irina Honin, Jonas Engelhardt, Andrea Schöler, Shannon T. Smith, Jens Meiler, Linda Schäker‐Hübner, Günther Weindl, Finn Kristian Hansen · 2024 · Bioorganic Chemistry
67. High levels of HDAC expression correlate with microglial aging
    Jaione Auzmendi-Iriarte, Leire Moreno‐Cugnon, Ander Saenz‐Antoñanzas, Daniela Grassi, Marian M. de Pancorbo, María‐Ángeles Arévalo, Ian C Wood, Ander Matheu · 2022 · Expert Opinion on Therapeutic Targets
68. DYRK1B regulates Hedgehog-induced microtubule acetylation
    Rajeev Kumar Singh, Philipp Simon Holz, Katrin Sabine Roth, Anna Hupfer, Wolfgang Meißner, Rolf Müller, Malte Buchholz, Thomas Mathias Gress, Hans‐Peter Elsässer, Ralf Jacob et al. · 2018 · Cellular and Molecular Life Sciences
69. Epigenetic Factors and Regulation of Meiotic Recombination in Mammals
    Pauline Barthès, Jérôme Buard, Bernard de Massy · 2010 · Epigenetics and human health
70. Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells
    Katie L. Togher, Louise C. Kenny, Gerard W. O’Keeffe · 2017 · International Journal of Cell Biology
71. The Shp2-induced epithelial disorganization defect is reversed by HDAC6 inhibition independent of Cdc42
    Sui-Chih Tien, Hsiao‐Hui Lee, Ya-Chi Yang, Miao‐Hsia Lin, Yu‐Ju Chen, Zee-Fen Chang · 2016 · Nature Communications
72. Pharmacologically induced proteolysis of histone deacetylase-6 attenuates influenza virus replication despite limited anti-tumor effects
    Johannes Jungwirth, Andreas O. Mieland, Andrea Piée‐Staffa, Tino Heimburg, Walburgis Brenner, Christina Ehrhardt, Wolfgang Sippl, Andreas Henke, Oliver Holger Krämer · 2025 · Life Sciences
73. A narrative review of the histone acetylation and deacetylation during mammalian spermatogenesis
    Tuba Kablan, Efe Biyikli, Nazlıcan Bozdemir, Fatma Uysal · 2024 · Biochimie
74. Histone acetylation regulated by histone deacetylases during spermatogenesis
    Xiangying Ou, Juan Yang, Linfeng Yang, Huihong Zeng, Lijian Shao · 2024 · Andrology
75. Opposing roles of HDAC6 in liver regeneration and hepatocarcinogenesis
    Sophors Phorl, Azra Memon, Yuri Seo, Thi Oanh Hoang, Trung Nghia Tran, Le Minh Tri Nguyen, Chang Hoon Lee, Woon Kyu Lee, Joo‐Yong Lee · 2022 · Cancer Science
76. M-134, a novel HDAC6-selective inhibitor, markedly improved arthritic severity in a rodent model of rheumatoid arthritis when combined with tofacitinib
    Daekwon Bae, Young‐Il Choi, Ji‐Young Lee, Nina Ha, Dong‐Hyeon Suh, Ji Yeon Baek, Jinsol Park, Woo‐Chan Son · 2020 · Pharmacological Reports
77. ACY‑1215, a HDAC6 inhibitor, decreases the dexamethasone‑induced suppression of osteogenesis in MC3T3‑E1 cells
    Na Wang, Hua Wang, Jianming Chen, Fubin Wang, Shuaiyi Wang, Qiang Zhou, Jichong Ying, Shanzhao Huang, Pu Wang, Fangfang Yuan · 2020 · Molecular Medicine Reports
78. Histone Deacetylase 6 as a Therapeutic Target in B cell-associated Hematological Malignancies
    Jia Nan Yang, Dengwen Li, Jun Zhou · 2020 · Frontiers in Pharmacology
79. HDAC6 activity is not required for basal autophagic flux in metastatic prostate cancer cells
    Gregory W. Watson, Samanthi I. Wickramasekara, Yufeng “Francis” Fang, Claudia S. Maier, David E Williams, Roderick H. Dashwood, Viviana Pérez, Emily Ho · 2015 · Experimental Biology and Medicine
80. Dido mutations trigger perinatal death and generate brain abnormalities and behavioral alterations in surviving adult mice
    Ricardo Villares, Julio Gutiérrez, Agnes Fütterer, Varvara Trachana, Fernando Gutiérrez del Burgo, Carlos Martínez‐A · 2015 · Proceedings of the National Academy of Sciences
81. Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons
    Saleem, Komal, Xiao, Zichun, Zhu, Binglin, Ren, Yong, Yan, Zhen, Feng, Jian · 2026 · Molecular Psychiatry
82. Histone Deacetylase Inhibitors Promote the Anticancer Activity of Cisplatin: Mechanisms and Potential
    Yang Zhou, Qun Luo, Liangzhen Gu, Xiao Tian, Yao Zhao, Yanyan Zhang, Fuyi Wang · 2025 · Pharmaceuticals
83. Structure–Activity Relationship of Propargylamine‐Based HDAC Inhibitors
    Matthias Wünsch, Johanna Senger, Philipp Schultheisz, Sabrina Schwarzbich, Karin Schmidtkunz, Carmela Michalek, Michaela Klaß, Stefanie Goskowitz, Philipp Borchert, Lucas Praetorius et al. · 2017 · ChemMedChem
84. Apico-basal Polarity Determinants Encoded by crumbs Genes Affect Ciliary Shaft Protein Composition, IFT Movement Dynamics, and Cilia Length
    Khodor S. Hazime, Jarema J. Malicki · 2017 · Genetics
85. Benzothiazole derivatives as histone deacetylase inhibitors for the treatment of autosomal dominant polycystic kidney disease.
    Xudong Cao, Zhiyuan Fan, Lingfang Xu, Wen-Chao Zhao, Haoran Zhang, Yunfang Yang, Ying Ren, Yuxian Xiao, Nan Zhou, Long Yin et al. · 2024 · European journal of medicinal chemistry
86. Pharmacophore-based virtual screening of ZINC database, molecular modeling and designing new derivatives as potential HDAC6 inhibitors
    Priya Poonia, Monika Sharma, Prakash K. Jha, Madhu Chopra · 2022 · Molecular Diversity
87. Suppression of FGFR3- and MYC-dependent oncogenesis by tubacin: association with HDAC6-dependent and independent activities
    Sara Ota, Zi-Qiang Zhou, Peter J. Hurlin · 2017 · Oncotarget
88. Cytoskeletal dynamics during in vitro neurogenesis of induced pluripotent stem cells (iPSCs)
    Claudia Compagnucci, Emanuela Piermarini, Antonella Sferra, Rossella Borghi, Alessia Niceforo, Stefania Petrini, Fiorella Piemonte, Enrico Bertini · 2016 · Molecular and Cellular Neuroscience
89. Developing histone deacetylase inhibitors in the therapeutic armamentarium of pancreatic adenocarcinoma
    Syed Farhan Zafar, Ganji Purnachandra Nagaraju, Bassel F. El‐Rayes · 2012 · Expert Opinion on Therapeutic Targets
90. Cilia at the crossroad: convergence of regulatory mechanisms to govern cilia dynamics during cell signaling and the cell cycle
    Lukáš Čajánek, Sindija Smite, Olha Ivashchenko, Martina Huranová · 2025 · Cell & Bioscience
91. Pharmacological manipulation of liver fibrosis progression using novel HDAC 6 inhibitors
    María Teresa Borrello, Dušan Ružić, Hannah L. Paish, Eleanor Graham, Amy Collins, Rebecca Scott, S. Higginbotham, B. Radović, Glyn Nelson, David M. Bulmer et al. · 2025 · FEBS Journal
92. Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design
    Milan Beljkaš, Miloš Petković, Ana M. Vuletić, Ana Djurić, Juan Francisco Santibanez, Tatjana Srdić‐Rajić, Katarina M. Nikolic, Slavica Oljačić · 2024 · Pharmaceutics
93. Novel biphenyl-based scaffold as potent and selective histone deacetylase 6 (HDAC6) inhibitors: Identification, development and pharmacological evaluation
    Xi Jin Xu, Di Zhang, Tengteng Zhao, Min Wang, Yu Li, Qianming Du, Junping Kou, Zhiyu Li, Jinlei Bian · 2022 · European Journal of Medicinal Chemistry
94. A review on the treatment of multiple myeloma with small molecular agents in the past five years
    Zhenzhen Zhang, Xin Liu, Liyun Zhao, Yaru Zhou, Jianyou Shi, Weini Chen, Jinqi Li · 2021 · European Journal of Medicinal Chemistry
95. Marginal band microtubules are acetylated by αTAT1
    A. Ribba, Morgane Batzenschlager, Clotilde Rabat, T. Buchou, S. Moog, S. Khochbin, E. Bourova-Flin, L. Lafanechère, F. Lanza, K. Sadoul · 2020 · Platelets
96. Screening and Identification of the Host Proteins Interacting with Toxoplasma gondii Rhoptry Protein ROP16
    Ming Pan, Yan-Qin Zhou, Yifan Wang, Longjiao Li, Yongle Song, Lun Hou, Jun-Long Zhao · 2017 · Frontiers in Microbiology
97. The Primary Cilium is a Self-Adaptable, Integrating Nexus for Mechanical Stimuli and Cell Signaling
    An M. Nguyen, Yuan-Nan Young, C. Jacobs · 2015
98. HDAC6 inhibition ameliorates sensory hypersensitivity and reduces immune cell signatures in the dorsal root ganglia in murine chronic pain models
    Ilinca M. Giosan, Randal A. Serafini, Aarthi Ramakrishnan, Madden J. Tuffy, Jeffrey H. Zimering, Alexandru Babeș, Li Shen, Venetia Zachariou · 2025 · Molecular Pharmacology
99. Therapeutic indications for HDAC6 inhibitors in the peripheral and central nervous disorders
    Jonathan M. van Eyll, Robert Ciarán Prior, Sylvain Célanire, Ludo Van Den Bosch, Frederik J. R. Rombouts · 2024 · Expert Opinion on Therapeutic Targets
100. Pathologically relevant aldoses and environmental aldehydes cause cilium disassembly via formyl group-mediated mechanisms
     Te Li, Min Liu, Yu Fan, Song Yang, Weiwen Bu, Kai Liu, Jia Nan Yang, Hua Ni, Mulin Yang, Hanxiao Yin et al. · 2023 · Journal of Molecular Cell Biology